AI assistant
Sending…
Translational Development Acquisition Corp. — Director's Dealing 2025
Jan 6, 2025
33592_dirs_2025-01-06_c018bc99-69e8-4f1f-a16a-6dccb0d18f0b.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Translational Development Acquisition Corp. (TDAC)
CIK: 0001926599
Period of Report: 2024-12-20
Reporting Person: Jarratt Christopher Kenneth (Director)
More from Translational Development Acquisition Corp.
Interim / Quarterly Report
2026
May 15
Annual Report
2026
May 11
Annual Report
2026
May 6
Interim / Quarterly Report
2025
Nov 14
Major Shareholding Notification
2025
Oct 10
Regulatory Filings
2025
Aug 14
Interim / Quarterly Report
2025
Aug 14
Major Shareholding Notification
2025
Jul 11
Interim / Quarterly Report
2025
May 15
Major Shareholding Notification
2025
May 14